U.S. Pelvic Fracture Patients Treated with New CurvaFix IM Implant
Novel, Curved Device Launches at Orthopaedic Trauma Association Meeting
BELLEVUE, Wash.--(BUSINESS WIRE)--#CurvaFixIMImplant--CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, announced today that the CurvaFix® IM Implant is now commercially available and being launched at the upcoming Orthopaedic Trauma Association (OTA) Annual Meeting, Oct. 20-23 in Fort Worth, Texas. The company will showcase the novel CurvaFix Implant in its booth (#422) and provide updates from recent U.S. cases using the CurvaFix Implant for fixation of pelvic and acetabular fractures.
“The curved boney pathways of the pelvis can present unique surgical challenges in traumatic fracture fixation with existing devices having some limitations,” said Samir Mehta, M.D., chief of the Division of Orthopaedic Trauma and Fracture Care and associate professor in Orthopaedic Surgery at Penn Medicine. “The new CurvaFix Implant has tremendous versatility allowing surgeons to follow the natural bone shape, filling the space, and achieving a stable construct. The flexible device is implanted percutaneously across the fracture and then locked in place, going from flexible to rigid, thereby maintaining fracture reduction. The patients we’ve treated using the new implant have tolerated their surgeries well.”
“With the commercial launch of the CurvaFix Implant, we believe a new clinical standard will be set in orthopedic trauma surgery for pelvic fixation and repair,” said Steve Dimmer, chief executive officer. “Our novel implantable device is the only intramedullary device capable of following the natural bone shape and filling the space within the pelvis. As such, our implant offers an option to improve pelvic trauma surgery for fracture fixation and repair that may result in less pain and improved mobility for patients compared to conventional techniques.”
The company also announced the addition of David Hovda to its board of directors. Mr. Hovda is president of MedTech Advisors and the former CEO of Simplify Medical, which was acquired by NuVasive in February 2021.
“I am extremely pleased to welcome Mr. Hovda to our board of directors,” said Dimmer. “He brings years of expertise as a medical device executive with deep experience in commercialization and outcome-driven innovation. He joins our board at an exciting time as we launch the CurvaFix Implant for orthopedic trauma.”
Pelvic fractures affect more than 165,000 people per year in the U.S.1 Often caused by car accidents or falls, these fractures are among the most serious and technically complex injuries treated by orthopedic trauma surgeons. Current surgical techniques with straight screws can be limited by bone curvature, and surgery with bone plates can require lengthy, invasive open procedures.
About CurvaFix, Inc.
CurvaFix, Inc. is a privately held medical device company headquartered in Bellevue, Wash. The idea for the company germinated when the former division head of orthopedic trauma at the University of British Columbia, Clinical Professor Emeritus, Robert Meek, M.D., FRCSC, believed there was a better way to repair pelvic fractures. Today, CurvaFix is developing implantable products to improve fracture repair in curved bones. The company’s first product is the CurvaFix IM Implant, which has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
CurvaFix is a trademark of CurvaFix, Inc., registered in the U.S.
1 2021 Trauma Update, Orthopedic Network News, Volume 32, No. 2, April 2021